Decisions of the Annual General Meeting of Scanfil plc on 27 April 2023

27.4.2023

Scanfil plc     Decisions of General Meeting         27 April 2023 at 4.00 p.m. EEST

Decisions of the Annual General Meeting of Scanfil plc on 27 April 2023

The Annual General Meeting of Scanfil plc was held without a meeting venue using a remote connection in real time on 27 April 2023 at 12.00 p.m. EEST in accordance with Section 8 of the Company’s Articles of Association and Chapter 5, Section 16 Subsection 3 of the Finnish Limited Liability Companies Act.

Scanfil plc’s Annual General Meeting has, in its meeting on 27 April 2023, confirmed the Financial Statements for 2022 and discharged the Board of Directors and the CEO from liability. The Annual General Meeting considered the Remuneration Report for Governing Bodies.

Dividend
According to the Board of Directors’ proposal, The Annual General Meeting decided to distribute a dividend total of EUR 0.21 per outstanding share. The record date for the payment of dividend is 2 May 2023, and the date of payment of the dividend is 9 May 2023.

The Board of Directors and the Auditor
The Meeting resolved that the Board of Directors consist of six members. Harri Takanen, Bengt Engström, Christina Lindstedt and Juha Räisänen were re-elected as members of the Board of Directors, and Minna Yrjönmäki and Thomas Dekorsy as new members of the Board of Directors.

In its meeting, held after the General Meeting, the Board of Directors elected Harri Takanen as the Chair of the Board of Directors. The Board further resolved to organize the Board committees as follows: the members of the Audit Committee are Juha Räisänen (chair), Christina Lindstedt and Minna Yrjönmäki, and the members of the Nomination and Compensation Committee are Harri Takanen (chair) and Bengt Engström.

Following the Annual General Meeting, the Board of Directors has reassessed the members’ independence. Thomas Dekorsy, Bengt Engström, Christina Lindstedt, Juha Räisänen and Minna Yrjönmäki are independent of the Company and major shareholders. Harri Takanen is not independent of the Company and major shareholders. A more detailed description of the independence assessment of the Board members is available on the Company’s website.

The meeting decided that the remuneration of Chair of the Board of Directors is EUR 4,800/month, and the remuneration of a member of the Board of Directors is EUR 3,000/month. Additionally, members of the Committee will receive a compensation of EUR 700/meeting and the Chair of the Audit Committee EUR 350/month. In addition, a fee of EUR 350 per face-to-face meeting held outside of the Board Members’ country of residence will be paid. Board members’ travel expenses are paid in accordance with the Company’s travel policy.

The remuneration for the auditor shall be paid against the auditor’s reasonable invoice.

KPMG Oy AB, a company of Authorized Public Accountants, continues as the Company’s auditor and the main auditor is CPA Janna Kivimäki. The auditor is appointed to a term ending to Annual General Meeting in 2024.

Authorization on the acquisition of the Company’s own shares
The Meeting decided according to the Board of Directors’ proposal to authorize the Board of Directors to decide on the acquisition of the Company’s own shares. The maximum number of the shares to be repurchased shall not exceed 5,000,000 shares. Company shares will be purchased with funds from the Company’s non-restricted equity, in which case the acquisition will decrease the Company’s distributable non-restricted equity.

Shares will be purchased in another proportion than that of the holdings of the current shareholders. Purchasing will take place through public trading arranged by Nasdaq Helsinki Oy at the market price on the date on which the acquisition is made or otherwise at a price formed on the market.

The authorization cancels the authorization given in the Annual General Meeting on 21 April 2022 to repurchase the Company’s own shares. The authorization will remain in force for 18 months after it is issued.

Authorization to decide on share issue, granting shares and issue of special rights entitling to shares
The Meeting decided according to the Board of Directors’ proposal to authorize the Board of Directors to decide on share issues and grating option rights.

The number of shares to be issued based on the authorization can be no more than 12,000,000 shares.

The Board shall decide on the terms and conditions of share issues. The authorization concerns both the issue of new shares and the transfer of treasury shares. Shares can be issued in deviation from the shareholders’ pre-emptive rights (directed issue).

The authorization cancels the authorization given in the Annual General Meeting on 21 April 2022 to decide on share issues and the issue of special rights entitling their holders to share. The authorization shall be valid until 30 June 2024.

The minutes of the Annual General Meeting will be available on the Company’s website, www.scanfil.com/agm, 11 May 2023 at the latest.

Scanfil plc

Additional information:
CEO Petteri Jokitalo
tel +358 8 4882 111

Scanfil is an international manufacturing partner and system supplier for the electronics industry with over 45 years of experience in demanding manufacturing. Scanfil provides its customers with an extensive array of services, ranging from product design to product manufacturing, material procurement and logistics solutions. Vertically integrated production and a comprehensive supply chain are the foundation of Scanfil’s competitive advantages: speed, flexibility and reliability.

Typical Scanfil products are modules or integrated products for e.g. self-service application, automation systems, wireless connectivity modules, climate control systems, collection and sorting systems, analyzers and weather solutions. Scanfil services are used by numerous international automation, safety, energy, cleantech and health service providers, as well as companies operating in the field of urbanisation. Scanfil’s network of factories consists of 9 production units in Europe, Asia and North America. Read more: www.scanfil.com  

Not to be published or distributed, directly or indirectly, in any country where its distribution or publication is unlawful. Forward looking statements: certain statements in this stock exchange release may constitute “forward-looking” statements which involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of Scanfil Oyj to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this stock exchange release, such statements use such words as “may,” “will,” “expect,” “anticipate,” “project,” “believe,” “plan” and other similar terminology. New risk factors may arise from time to time and it is not possible for management to predict all of those risk factors or the extent to which any factor or combination of factors may cause actual results, performance and achievements of Scanfil Oyj to be materially different from those contained in forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. The forward-looking information contained in this stock exchange release is current only as of the date of this stock exchange release. There should not be an expectation that such information will in all circumstances be updated, supplemented or revised, except as provided by the law or obligatory regulations, whether as a result of new information, changing circumstances, future events or otherwise.

Attachments